Infectious Diseases News and Research

RSS

Researchers develop highly scalable and accurate antibody test for COVID-19

An antibody test for the virus that causes COVID-19, developed by researchers at The University of Texas at Austin in collaboration with Houston Methodist and other institutions, is more accurate and can handle a much larger number of donor samples at lower overall cost than standard antibody tests currently in use.

14 Sep 2020

New study can help develop effective COVID-19 vaccine

According to a new study, a detailed analysis of antibody responses in patients affected by COVID-19 could help develop an effective vaccine.

14 Sep 2020

Computer-designed proteins protect lab-grown human cells from SARS-CoV-2

Computer-designed small proteins have now been shown to protect lab-grown human cells from SARS-CoV-2, the coronavirus that causes COVID-19.

10 Sep 2020

Researchers discover the developmental process of strong immune T-cells

There are memory cells that remember previously encountered pathogens and help to react quickly and strongly when exposed to them again.

4 Sep 2020

Study shows cell surface proteins in placental tissue prevent COVID-19 transmission

Scientists from the Maxwell Finland Laboratory for Infectious Diseases at Boston Medical Center have discovered properties in the placental tissue that may play a significant role in inhibiting the transmission of COVID-19 infection from a mother, who has the novel coronavirus, to her fetus.

3 Sep 2020

Researchers discover the developmental process of novel immune T cells

Memory cells essentially recall formerly encountered pathogens and help respond strongly and rapidly when they are exposed to this foreign matter again.

3 Sep 2020

Decisions of small-scale poultry farmers can influence the spread of deadly virus

Small-scale poultry farmers in Vietnam tend to respond to viral outbreaks of highly pathogenic avian influenza (HPAI) by rapidly selling their birds as a way to avoid financial loss, according to a new study by an international team of researchers.

31 Aug 2020

New cellular pathway can protect cells from infection by Ebola virus, coronavirus

Discoveries from the Benaroya Research Institute at Virginia Mason (BRI) have identified a new cellular protection pathway that targets a common vulnerability in several different pandemic viruses, and collaborators at Case Western Reserve University, Boston University School of Medicine and MRIGlobal have shown that this pathway can protect cells from infection by Ebola virus and coronaviruses, like SARS-CoV-2.

28 Aug 2020

First lethal mouse model established for COVID-19 infection

Army scientists have developed the first lethal mouse model of SARS-CoV-2, the virus that causes COVID-19, using mice that were genetically engineered to express the human ACE2 gene--a key mechanism by which the virus enters human cells.

28 Aug 2020

Study shows how individualization with pharmacogenomics could impact COVID-19 treatments

Over the past few months, a number of drugs have been under investigation to treat COVID-19 without well-established safety or data to support these claims.

28 Aug 2020

Scientists identify antigen valencies that work best in vaccine designs for HIV, SARS-CoV-2

Designing a vaccine starts with finding the right ingredients. Every infectious agent has molecules, called antigens, that the immune system could potentially recognize and attack. So scientists must carefully consider which antigens should go into a vaccine.

28 Aug 2020

Each person's gut has a unique viral 'fingerprint'

Each person's gut virus composition is as unique as a fingerprint, according to the first study to assemble a comprehensive database of viral populations in the human digestive system.

25 Aug 2020

Lasting nature of IBD linked to long-lived immune cell that causes persistent inflammation

Inflammatory bowel disease (IBD) is a group of intestinal disorders affecting an estimated six to eight million people worldwide.

25 Aug 2020

Microsoft's AI supports the development of Vaxine's COVAX-19 vaccine

Given the global urgency of the COVID-19 pandemic, Microsoft's AI for Health program has stepped in to support the development and potential deployment of Vaxine's COVAX-19™ vaccine with a philanthropic grant.

25 Aug 2020

Study: Wastewater containing coronaviruses may be a serious threat

Wastewater containing coronaviruses may be a serious threat, according to a new, global study led by researchers from the Zuckerberg Institute for Water Research at Ben-Gurion University of the Negev (BGU).

25 Aug 2020

Researchers develop multiplex genetic diagnostic device for early detection, prevention of crop diseases

A research group composed of Professor Takayuki Shibata and his colleagues at the Department of Mechanical Engineering, Toyohashi University of Technology has applied a microfluidic chip technology to develop a multiplex genetic diagnostic device for the early detection and prevention of crop diseases.

24 Aug 2020

Cytokine storms in COVID-19 patients may prevent the development of long-term immunity

Shiv Pillai, MD, Ph.D., investigator in the Ragon Institute of MGH, MIT and Harvard and professor at Harvard Medical School (HMS), recently published a paper in Cell showing that that high levels of some cytokines seen in COVID-19 patients, as part of a cytokine storm, may prevent the development of long-term immunity to SARS-CoV-2, the virus that causes COVID-19.

20 Aug 2020

Greater gut microbial diversity in kidney cancer patients linked to better treatment outcomes

Physicians at City of Hope, working in collaboration with scientists at Translational Genomics Research Institute (TGen), have found that greater gut microbial diversity in patients with metastatic kidney cancer is associated with better treatment outcomes on Food and Drug Administration-approved immunotherapy regimens.

20 Aug 2020

Influenza viruses can spread through the air on dust, fibers

Influenza viruses can spread through the air on dust, fibers and other microscopic particles, according to new research from the University of California, Davis and the Icahn School of Medicine at Mt. Sinai.

From The University of California, Davis 19 Aug 2020

Novel receptor protein can be a promising treatment for COVID-19

A novel receptor protein that binds to the SARS-CoV-2 virus and prevents it from entering cells may hold promise for treating COVID-19 and other coronavirus-related diseases, according to research published online Aug. 4 in the journal SCIENCE.

18 Aug 2020

Infectious Diseases News and Research

Researchers develop highly scalable and accurate antibody test for COVID-19

New study can help develop effective COVID-19 vaccine

Computer-designed proteins protect lab-grown human cells from SARS-CoV-2

Researchers discover the developmental process of strong immune T-cells

Study shows cell surface proteins in placental tissue prevent COVID-19 transmission

Researchers discover the developmental process of novel immune T cells

Decisions of small-scale poultry farmers can influence the spread of deadly virus

New cellular pathway can protect cells from infection by Ebola virus, coronavirus

First lethal mouse model established for COVID-19 infection

Study shows how individualization with pharmacogenomics could impact COVID-19 treatments

Scientists identify antigen valencies that work best in vaccine designs for HIV, SARS-CoV-2

Each person's gut has a unique viral 'fingerprint'

Lasting nature of IBD linked to long-lived immune cell that causes persistent inflammation

Microsoft's AI supports the development of Vaxine's COVAX-19 vaccine

Study: Wastewater containing coronaviruses may be a serious threat

Researchers develop multiplex genetic diagnostic device for early detection, prevention of crop diseases

Cytokine storms in COVID-19 patients may prevent the development of long-term immunity

Greater gut microbial diversity in kidney cancer patients linked to better treatment outcomes

Influenza viruses can spread through the air on dust, fibers

Novel receptor protein can be a promising treatment for COVID-19

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics